Pathogenesis of Arrhythmogenic Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Arrhythmogenic cardiomyopathy (ACM) is a primary myocardial disease.
• Characterized by ventricular arrhythmias and sudden cardiac death risk, often preceding significant myocardial remodeling.
• Histopathology reveals fibrofatty replacement of myocardium, typically affecting the right ventricular free wall.

Purpose of the Study:

• To review current understanding of ACM pathogenesis.
• To highlight key molecular and cellular mechanisms involved in ACM.
• To identify future research directions in ACM.

Main Methods:

• Literature review of recent advances in ACM research.
• Analysis of genetic studies, particularly desmosomal gene mutations.
• Examination of signaling pathways (Wnt/β-catenin, Hippo) and protein trafficking defects.

Main Results:

• Over 60% of ACM probands have mutations in desmosomal genes, suggesting impaired cell-cell adhesion.
• Evidence implicates inflammation and exercise in increasing disease penetrance and progression.
• Aberrant Wnt/β-catenin and Hippo signaling pathways are implicated in ACM pathogenesis.
• Defects in protein trafficking to the intercalated disk are also noted.

Conclusions:

• ACM pathogenesis is multifactorial, involving genetic predisposition, environmental factors, and disrupted cellular signaling.
• Further research into these pathways and their interactions is crucial for developing targeted therapies.
• Understanding these mechanisms will aid in predicting disease progression and improving outcomes for ACM patients.